Invesaro

Stocks Comparison

Baxter International vs Stryker: revenue, profit, margins and growth compared

Baxter International brought in $11.2B of revenue in fiscal 2025, Stryker $25.1B in fiscal 2025. Revenue changed by +5.7% at Baxter International and +11.2% at Stryker on the year before, so Stryker grew faster. Baxter International kept -8.5% of its revenue as net profit, Stryker 12.9%. Free cash flow was $332M at Baxter International and $4.3B at Stryker.

Side by side, latest fiscal year

BAXSYK
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$11.2B$25.1B
Revenue growth+5.7%+11.2%
Net income-$957M$3.2B
Net margin-8.5%12.9%
Free cash flow$332M$4.3B
Free cash flow margin3.0%17.1%
Earnings per share (diluted)-$1.87$8.40
Cash$2B$4B
Debt$9.4B$14.9B
Price to earningsn/a32.4
Market value$12.1B$104.5B
Dividend yield2.23%n/a
Rank by revenue in sector#42 of 523 · Health care#24 of 523 · Health care

Over the years

Revenue
BAX FY2018: $11.1BBAX FY2019: $11.4BBAX FY2020: $11.7BBAX FY2021: $12.1BBAX FY2022: $10.1BBAX FY2023: $10.4BBAX FY2024: $10.6BBAX FY2025: $11.2BSYK FY2018: $13.6BSYK FY2019: $14.9BSYK FY2020: $14.4BSYK FY2021: $17.1BSYK FY2022: $18.4BSYK FY2023: $20.5BSYK FY2024: $22.6BSYK FY2025: $25.1BFY18FY19FY20FY21FY22FY23FY24FY25
BAX $11.2BSYK $25.1B
Net income
BAX FY2018: $1.5BBAX FY2019: $1BBAX FY2020: $1.1BBAX FY2021: $1.3BBAX FY2022: -$2.4BBAX FY2023: $2.7BBAX FY2024: -$649MBAX FY2025: -$957MSYK FY2018: $3.6BSYK FY2019: $2.1BSYK FY2020: $1.6BSYK FY2021: $2BSYK FY2022: $2.4BSYK FY2023: $3.2BSYK FY2024: $3BSYK FY2025: $3.2BFY18FY19FY20FY21FY22FY23FY24FY25
BAX -$957MSYK $3.2B
Net margin
BAX FY2018: 13.9%BAX FY2019: 8.8%BAX FY2020: 9.4%BAX FY2021: 10.6%BAX FY2022: -24.2%BAX FY2023: 25.6%BAX FY2024: -6.1%BAX FY2025: -8.5%SYK FY2018: 26.1%SYK FY2019: 14.0%SYK FY2020: 11.1%SYK FY2021: 11.7%SYK FY2022: 12.8%SYK FY2023: 15.4%SYK FY2024: 13.2%SYK FY2025: 12.9%FY18FY19FY20FY21FY22FY23FY24FY25
BAX -8.5%SYK 12.9%
Revenue growth
BAX FY2019: +2.4%BAX FY2020: +2.7%BAX FY2021: +4.1%BAX FY2022: -17.2%BAX FY2023: +3.0%BAX FY2024: +2.7%BAX FY2025: +5.7%SYK FY2019: +9.4%SYK FY2020: -3.6%SYK FY2021: +19.2%SYK FY2022: +7.8%SYK FY2023: +11.1%SYK FY2024: +10.2%SYK FY2025: +11.2%FY19FY20FY21FY22FY23FY24FY25
BAX +5.7%SYK +11.2%
Free cash flow
BAX FY2018: $1.4BBAX FY2019: $1.4BBAX FY2020: $1.2BBAX FY2021: $1.5BBAX FY2022: $834MBAX FY2023: $1.3BBAX FY2024: $573MBAX FY2025: $332MSYK FY2018: $2BSYK FY2019: $1.5BSYK FY2020: $2.8BSYK FY2021: $2.7BSYK FY2022: $2BSYK FY2023: $3.1BSYK FY2024: $3.5BSYK FY2025: $4.3BFY18FY19FY20FY21FY22FY23FY24FY25
BAX $332MSYK $4.3B

Fiscal years as each company reports them; the two may end in different months.

Questions about Baxter International and Stryker

Which is bigger by revenue, Baxter International or Stryker?

Stryker is bigger by revenue: $25.1B in fiscal 2025, against $11.2B for Baxter International in fiscal 2025.

Which keeps more of its revenue as profit, Baxter International or Stryker?

Baxter International had a net margin of -8.5% in fiscal 2025; Stryker had 12.9% in fiscal 2025.

Which grew revenue faster, Baxter International or Stryker?

In their latest fiscal years revenue changed by +5.7% at Baxter International and +11.2% at Stryker.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies